Our Mission
GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care.
With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes.
Latest News
Application to FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
GBS Inc. Announces Application to FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test New York, NY, December 13, 2021 – GBS Inc. (Nasdaq: GBS), a life sciences […]
With our world-first Biosensor Platform technology, GBS Inc. will develop and launch two urgently needed non-invasive, real-time diagnostic tests.
Behind the Technology
Meet the team at the Centre for Organic Electronics behind the biosensor technology.
